AMICUS THERAPEUTICS INC's ticker is FOLD and the CUSIP is 03152W109. A total of 226 filers reported holding AMICUS THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.62 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $4,860,720 | +43.7% | 387,000 | +26.9% | 0.60% | -11.6% |
| Q1 2023 | $3,382,450 | -15.3% | 305,000 | -6.7% | 0.68% | -18.7% |
| Q4 2022 | $3,992,670 | +194.2% | 327,000 | +151.5% | 0.84% | +217.4% |
| Q3 2022 | $1,357,000 | -82.1% | 130,000 | -81.5% | 0.26% | -83.0% |
| Q2 2022 | $7,566,000 | +256.7% | 704,490 | +214.5% | 1.56% | +181.9% |
| Q1 2022 | $2,121,000 | +4.9% | 224,000 | +28.0% | 0.55% | -1.3% |
| Q4 2021 | $2,021,000 | -50.2% | 175,000 | -58.8% | 0.56% | -52.1% |
| Q3 2021 | $4,059,000 | -11.4% | 425,000 | -10.5% | 1.17% | -7.5% |
| Q2 2021 | $4,579,000 | – | 475,000 | – | 1.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 10,524,022 | $127,972,108 | 12.11% |
| Perceptive Advisors | 27,692,917 | $336,745,870 | 11.23% |
| Redmile Group, LLC | 16,944,621 | $206,046,591 | 9.80% |
| Finepoint Capital LP | 1,489,025 | $18,106,544 | 9.02% |
| CM Management, LLC | 450,000 | $5,472,000 | 5.81% |
| Avoro Capital Advisors LLC | 27,400,000 | $333,184,000 | 5.20% |
| MPM BioImpact LLC | 716,139 | $8,708,250 | 2.32% |
| Artal Group S.A. | 4,062,567 | $49,401 | 2.12% |
| SECTORAL ASSET MANAGEMENT INC | 803,464 | $9,770,122 | 1.90% |
| GREAT POINT PARTNERS LLC | 857,000 | $10,421,120 | 1.90% |